ARCHIVES

UCSF Gets $20 Million For Stem Cell Research Building

This article is from The Cancer Letter archive.

Vol. 37 No. 05 | February 4, 2011

Download PDF Visit The Full Archive

Related Articles

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

Group Urges Journals To Run Corrections For I-ELCAP Papers.

January 25, 2008

UCLA, NYU, Ohio States Must Wait Longer For Comprehensive Status

November 28, 1975

Breast Cancer Awareness High, Knowledge Of Facts Low,

October 5, 2007

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

July 25, 2014

Stand Up To Cancer Launches Immunology “Dream Team”

December 14, 2012